Literature DB >> 16988523

Effects of infant sex on mother-to-child transmission of HIV-1 according to timing of infection in Zimbabwe.

Ellen G Piwoz1, Jean H Humphrey, Edmore T Marinda, Kuda Mutasa, Lawrence H Moulton, Peter J Iliff.   

Abstract

We examined the relationship between sex and the risk of intrauterine, intrapartum and postnatal HIV transmission among 4495 infants born to HIV-infected mothers in Harare, Zimbabwe. Intrauterine transmission was 8.6%, and consistent with other studies was higher among girl than boy infants (AOR 1.53; 95% CI 1.23-1.91). Unlike previous studies, we observed no independent effect of infant sex on intrapartum or breastfeeding-associated HIV transmission. Sex-specific postnatal prevention strategies are not warranted in this population.

Entities:  

Mesh：

Year:  2006        PMID： 16988523     DOI： 10.1097/01.aids.0000247123.04703.6e

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


  7 in total

1.  Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa.

Authors:  Risa M Hoffman; Vivian Black; Karl Technau; Karin Joan van der Merwe; Judith Currier; Ashraf Coovadia; Matthew Chersich
Journal:  J Acquir Immune Defic Syndr       Date:  2010-05-01       Impact factor: 3.731

2.  An imputation method for interval censored time-to-event with auxiliary information: analysis of the timing of mother-to-child transmission of HIV.

Authors:  Elizabeth R Brown; Ying Qing Chen
Journal:  Stat Commun Infect Dis       Date:  2010-12-21

3.  Antenatal HIV-1 RNA load and timing of mother to child transmission; a nested case-control study in a resource poor setting.

Authors:  Kerina Duri; Felicity Z Gumbo; Knut I Kristiansen; Nyaradzi E Kurewa; Munyaradzi P Mapingure; Simbarashe Rusakaniko; Mike Z Chirenje; Fredrik Muller; Babill Stray-Pedersen
Journal:  Virol J       Date:  2010-08-02       Impact factor: 4.099

4.  Strong sex bias in elite control of paediatric HIV infection.

Authors:  Vinicius A Vieira; Peter Zuidewind; Maximilian Muenchhoff; Julia Roider; Jane Millar; Margaret Clapson; Anriette Van Zyl; Delane Shingadia; Emily Adland; Rohin Athavale; Nicholas Grayson; M Azim Ansari; Christian Brander; Claudia Fortuny Guash; Lars Naver; Thanyawee Puthanakit; Wipaporn Natalie Songtaweesin; Jintanat Ananworanich; Denise Peluso; Beatriz Thomé; Jorge Pinto; Pieter Jooste; Gareth Tudor-Williams; Mark F Cotton; Philip Goulder
Journal:  AIDS       Date:  2019-01-27       Impact factor: 4.177

5.  [Study of risk factors for HIV transmission from mother to child in the strategy «option A» in Lubumbashi, Democratic Republic of Congo].

Authors:  Dieudonné Tshikwej Ngwej; Olivier Mukuku; Rachel Mudekereza; Eugénie Karaj; Etienne Bwana Fwamba Odimba; Oscar Numbi Luboya; Jean-Baptiste Sakatolo Kakoma; Stanis Okitotshio Wembonyama
Journal:  Pan Afr Med J       Date:  2015-09-09

6.  HIGH-FREQUENCY failure of combination antiretroviral therapy in paediatric HIV infection is associated with unmet maternal needs causing maternal NON-ADHERENCE.

Authors:  Jane R Millar; Nomonde Bengu; Rowena Fillis; Ken Sprenger; Vuyokazi Ntlantsana; Vinicius A Vieira; Nisreen Khambati; Moherndran Archary; Maximilian Muenchhoff; Andreas Groll; Nicholas Grayson; John Adamson; Katya Govender; Krista Dong; Photini Kiepiela; Bruce D Walker; David Bonsall; Thomas Connor; Matthew J Bull; Nelisiwe Nxele; Julia Roider; Nasreen Ismail; Emily Adland; Maria C Puertas; Javier Martinez-Picado; Philippa C Matthews; Thumbi Ndung'u; Philip Goulder
Journal:  EClinicalMedicine       Date:  2020-05-08

7.  Sex Differences in Antiretroviral Therapy Initiation in Pediatric HIV Infection.

Authors:  Masahiko Mori; Emily Adland; Paolo Paioni; Alice Swordy; Luisa Mori; Leana Laker; Maximilian Muenchhoff; Philippa C Matthews; Gareth Tudor-Williams; Nora Lavandier; Anriette van Zyl; Jacob Hurst; Bruce D Walker; Thumbi Ndung'u; Andrew Prendergast; Philip Goulder; Pieter Jooste
Journal:  PLoS One       Date:  2015-07-07       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.